Nanoxis is currently collaborating with AstraZeneca, BioInvent and Health Protection Agency in England amongst others and is always looking for new scientific collaboration partners with interesting projects to develop exciting applications and protocols. Our current priority lies within further development of the following applications using our LPI™ Technology:

• Ligand binding studies
• Phage display library screening
• Identification of posttranslational modifications
• Absolute quantification

Contact us for collaboration opportunities